Cell-derived microparticles in stored blood products: Innocent-bystanders or effective mediators of post-transfusion reactions?

Blood Transfusion

Volumn 10, Issue SUPPL. 2, 2012, Pages

  Kriebardis, Anastasios ^a   Antonelou, Marianna ^b   Stamoulis, Konstantinos ^c   Papassideri, Issidora S ^b  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Blood Transfusion Centre   (Greece)

Author keywords

Blood products; Microparticles; Microvesiculation; Transfusion reactions

Indexed keywords

BIOLOGICAL MARKER; DNA FRAGMENT;

ANGIOGENESIS; APOPTOSIS; BLOOD TRANSFUSION REACTION; BYSTANDER EFFECT; CELL ACTIVATION; CELL BUDDING; CELL DAMAGE; CELL MEMBRANE; CELL VACUOLE; CYTOSKELETON; DNA FRAGMENTATION; ENDOCYTOSIS; ERYTHROCYTE; EXOSOME; HUMAN; INTERNALIZATION; MEMBRANE MICROPARTICLE; NONHUMAN; PLASMAPHERESIS; REVIEW; SHEAR STRESS; THROMBOCYTE; TRANSMISSION ELECTRON MICROSCOPY; BLOOD STORAGE; BLOOD TRANSFUSION;

BLOOD PRESERVATION; BLOOD TRANSFUSION; CELL-DERIVED MICROPARTICLES; HUMANS;

EID: 84861774492     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.006S     Document Type: Review

References (113)

1. Gyorgy B, Szabo TG, Pasztoi M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-88.
2. De Maio A. Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones 2011; 16(3): 235-49.
3. Diehl P, Fricke A, Sander L, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012; 93: 633-44.
4. Jin M, Drwal G, Bourgeois T, et al. Distinct proteome features of plasma microparticles. Proteomics 2005; 5: 1940-52. (Pubitemid 40686238)
5. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047-57.
6. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res 2012; 110: 356-69.
7. Baron M, Boulanger CM, Staels B, Tailleux A. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med 2011; DOI: 10.1111/j.1582-4934.2011.01486.x.
8. Rubin O, Crettaz D, Canellini G, et al. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008; 95: 288-97.
9. Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-34. (Pubitemid 46437805)
10. Connor DE, Exner T, Ma DD, Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 1044-52.
11. Vandromme MJ, McGwin G Jr, Marques MB, et al. Transfusion and pneumonia in the trauma intensive care unit: an examination of the temporal relationship. J Trauma 2009; 67: 97-101.
12. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39. (Pubitemid 351439224)
13. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion- associated postoperative infection. Transfus Med Rev 2002; 16: 144-60. (Pubitemid 34292974)
14. Vamvakas EC. White-blood-cell-containing allogeneic blood transfusion, postoperative infection and mortality: a meta-analysis of observational 'before-and-after' studies. Vox Sang 2004; 86: 111-9. (Pubitemid 38436889)
15. Jensen LS, Puho E, Pedersen L, et al. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 2005; 365: 681-2. (Pubitemid 40260890)
16. Rubin O, Crettaz D, Tissot JD, Lion N. Microparticles in stored red blood cells: submicron clotting bombs? Blood Transfus 2010; 8 (Suppl 3): s31-8.
17. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51. (Pubitemid 40197488)
18. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 2008; 48: 1943-53.
19. Antonelou MH, Kriebardis AG, Stamoulis KE, et al. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose- mannitol. Transfusion 2010; 50: 376-89.
20. Antonelou MH, Kriebardis AG, Stamoulis KE, et al. Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation. PLoS One 2011; 6: e26033.
21. Bosman GJ, Lasonder E, Luten M, et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008; 48: 827-35. (Pubitemid 351614907)
22. Garcia BA, Smalley DM, Cho H, et al. The platelet microparticle proteome. J Proteome Res 2005; 4: 1516-21. (Pubitemid 41464776)
23. Joop K, Berckmans RJ, Nieuwland R, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001; 85: 810-20. (Pubitemid 32421813)
24. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-83. (Pubitemid 37193612)
25. Aras O, Shet A, Bach RR, et al. Induction of microparticle-and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103: 4545-53. (Pubitemid 38745982)
26. Ueba T, Haze T, Sugiyama M, et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost 2008; 100: 280-5.
27. Ay C, Freyssinet JM, Sailer T, et al. Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb Res 2009; 123: 724-6.
28. Rubin O, Crettaz D, Tissot JD, Lion N. Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta 2010; 82: 1-8.
29. Ayers L, Kohler M, Harrison P, et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011; 127: 370-7.
30. Miyazaki Y, Nomura S, Miyake T, et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88: 3456-64. (Pubitemid 26365580)
31. Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood 1991; 77: 887-95.
32. Lion N, Crettaz D, Rubin O, Tissot JD. Stored red blood cells: a changing universe waiting for its map(s). J Proteomics 2010; 73: 374-85.
33. Antonelou MH, Kriebardis AG, Papassideri IS. Aging and death signalling in mature red cells: from basic science to transfusion practice. Blood Transfus 2010; 8 (Suppl 3): s39-47.
34. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007; 104: 17063-8. (Pubitemid 350210992)
35. Gevi F, D'Alessandro A, Rinalducci S, Zolla L. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012; DOI: 10.1016/j. prot.2012.03.012.
36. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion 2007; 47: 1212-20. (Pubitemid 46934313)
37. Kriebardis AG, Antonelou MH, Stamoulis KE, et al. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med 2007; 11: 148-55. (Pubitemid 46439633)
38. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009; 96: 93-103.
39. Card RT, Mohandas N, Mollison PL. Relationship of post-transfusion viability to deformability of stored red cells. Br J Haematol 1983; 53: 237-40. (Pubitemid 13171496)
40. Gov N, Cluitmans J, Sens P, Bosman GJCGM. Cytoskeletal Control of Red Blood Cell Shape: Theory and Practice of Vesicle Formation. In: Leitmannova Liu A, Iglic A (editors). Advances in Planar Lipid Bilayers and Liposomes, Vol 10. Oxford: Elsevier; 2009. p. 95-119.
41. Ferru E, Giger K, Pantaleo A, et al. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood 2011; 117: 5998-6006.
42. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26. (Pubitemid 41811224)
43. Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, et al. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 2003; 101: 747-51. (Pubitemid 36077602)
44. Greenwalt TJ. The how and why of exocytic vesicles. Transfusion 2006; 46: 143-52. (Pubitemid 43381798)
45. Tissot JD, Rubin O, Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010; 17: 571-7.
46. Hess JR. Red cell changes during storage. Transfus Apher Sci 2010; 43: 51-9.
47. Salzer U, Zhu R, Luten M, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008; 48: 451-62. (Pubitemid 351294572)
48. Rumsby MG, Trotter J, Allan D, Michell RH. Recovery of membrane micro-vesicles from human erythrocytes stored for transfusion: a mechanism for the erythrocyte discocyte-to-spherocyte shape transformation. Biochem Soc Trans 1977; 5: 126-8.
49. Greenwalt TJ, Zehner Sostok C, Dumaswala UJ. Studies in red blood cell preservation. 1. Effect of the other formed elements. Vox Sang 1990; 58: 85-9. (Pubitemid 20121365)
50. Gov NS, Safran SA. Red blood cell membrane fluctuations and shape controlled by ATP-induced cytoskeletal defects. Biophys J 2005; 88: 1859-74. (Pubitemid 40976199)
51. Sens P, Gov N. Force balance and membrane shedding at the red-blood-cell surface. Phys Rev Lett 2007; 98: 018102.
52. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev 2001; 15: 91-107. (Pubitemid 32303574)
53. Pantaleo A, Ferru E, Carta F, et al. Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells. PLoS One 2011; 6: e15847.
54. Wolfe LC, Byrne AM, Lux SE. Molecular defect in the membrane skeleton of blood bank-stored red cells. Abnormal spectrin-protein 4.1-actin complex formation. J Clin Invest 1986; 78: 1681-6. (Pubitemid 17219533)
55. Wagner GM, Chiu DT, Qju JH, et al. Spectrin oxidation correlates with membrane vesiculation in stored RBCs. Blood 1987; 69: 1777-81. (Pubitemid 17091640)
56. Bosman GJ, Werre JM, Willekens FL, Novotny VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-47.
57. Willekens FL, Werre JM, Groenen-Dopp YA, et al. Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol 2008; 141: 549-56. (Pubitemid 351550554)
58. Berezina TL, Zaets SB, Morgan C, et al. Influence of storage on red blood cell rheological properties. J Surg Res 2002; 102: 6-12.
59. Blasi B, D'Alessandro A, Ramundo N, Zolla L. Red blood cell storage and cell morphology. Transfus Med 2012; 22: 90-6.
60. Bosman GJ, Lasonder E, Groenen-Dopp YA, et al. Comparative proteomics of erythrocyte aging in vivo and in vitro. J Proteomics 2010; 73: 396-402.
61. Dumaswala UJ, Dumaswala RU, Levin DS, Greenwalt TJ. Improved red blood cell preservation correlates with decreased loss of bands 3, 4.1, acetylcholinestrase, and lipids in microvesicles. Blood 1996; 87: 1612-6. (Pubitemid 26056929)
62. Jy W, Ricci M, Shariatmadar S, et al. Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011; 51: 886-93.
63. van Beers EJ, Schaap MC, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513-9.
64. Xiong Z, Cavaretta J, Qu L, et al. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011; 51: 610-21.
65. Greenwalt TJ, Dumaswala UJ. Effect of red cell age on vesiculation in vitro. Br J Haematol 1988; 68: 465-7.
66. Cardo LJ, Wilder D, Salata J. Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus Apher Sci 2008; 38: 117-25.
67. Belizaire RM, Prakash PS, Richter JR, et al. Microparticles from Stored Red Blood Cells Activate Neutrophils and Cause Lung Injury after Hemorrhage and Resuscitation. J Am Coll Surg 2012; PMID: 22342784.
68. Schnabel RB, Baumert J, Barbalic M, et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2010; 115: 5289-99.
69. Tung JP, Fung YL, Nataatmadja M, et al. A novel in vivo ovine model of transfusion-related acute lung injury (TRALI). Vox Sang 2011; 100: 219-30.
70. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108: 2455-62. (Pubitemid 44497533)
71. Oreskovic RT, Dumaswala UJ, Greenwalt TJ. Expression of blood group antigens on red cell microvesicles. Transfusion 1992; 32: 848-9. (Pubitemid 23001633)
72. Sadallah S, Eken C, Schifferli JA. Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol 2008; 84: 1316-25.
73. Donadee C, Raat NJ, Kanias T, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465-76.
74. Kim-Shapiro DB, Lee J, Gladwin MT. Storage lesion: role of red blood cell breakdown. Transfusion 2011; 51: 844-51.
75. Sloand EM, Mainwaring L, Keyvanfar K, et al. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria. Blood 2004; 104: 3782-8. (Pubitemid 39564458)
76. Liu R, Klich I, Ratajczak J, et al. Erythrocyte-derived microvesicles may transfer phosphatidylserine to the surface of nucleated cells and falsely 'mark' them as apoptotic. Eur J Haematol 2009; 83: 220-9.
77. Distler JH, Huber LC, Gay S, et al. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006; 39: 683-90. (Pubitemid 44964371)
78. Keating FK, Butenas S, Fung MK, Schneider DJ. Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells. Transfusion 2011; 51: 1086-95.
79. Blajchman MA, Beckers EA, Dickmeiss E, et al. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005; 19: 259-72. (Pubitemid 41415653)
80. Schubert P, Culibrk B, Coupland D, et al. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2012; 52: 397-408.
81. Murphy S, Gardner FH. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971; 50: 370-7.
82. Shrivastava M. The platelet storage lesion. Transfus Apher Sci 2009; 41: 105-13.
83. George JN, Pickett EB, Heinz R. Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates. Transfusion 1988; 28: 123-6.
84. DiMinno G, Silver MJ, Murphy S. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. Blood 1982; 59: 563-8. (Pubitemid 12187475)
85. Ribeiro A, Swann JC, Berndt MC. Alterations of the levels of glycoproteins Ib-IX and IIb-IIIa in platelets stored at 22 degrees C. Thromb Res 1992; 66: 619-27.
86. Canault M, Duerschmied D, Brill A, et al. p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood 2010; 115: 1835-42.
87. Thiele T, Steil L, Gebhard S, et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007; 47: 1221-33. (Pubitemid 46934314)
88. Thon JN, Schubert P, Devine DV. Platelet storage lesion: a new understanding from a proteomic perspective. Transfus Med Rev 2008; 22: 268-79.
89. Seghatchian J, Krailadsiri P. Current position on preparation and quality of leucodepleted platelet concentrates for clinical use. Transfus Sci 2000; 22: 85-8. (Pubitemid 30195860)
90. Curvers J, van Pampus EC, Feijge MA, et al. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004; 44: 49-58. (Pubitemid 38177136)
91. Fox JE, Austin CD, Reynolds CC, Steffen PK. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991; 266: 13289-95. (Pubitemid 21907342)
92. Yano Y, Kambayashi J, Shiba E, et al. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J 1994; 299: 303-8. (Pubitemid 24106323)
93. Morel O, Morel N, Jesel L, et al. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 2011; 33: 469-86.
94. Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 2010; 6: 21-9.
95. Bode AP, Knupp CL. Effect of cold storage on platelet glycoprotein Ib and vesiculation. Transfusion 1994; 34: 690-6. (Pubitemid 24270114)
96. Krailadsiri P, Seghatchian J. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets. Vox Sang 2000; 78: 171-5.
97. Rank A, Nieuwland R, Liebhardt S, et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang 2011; 100: 179-86.
98. Boing AN, Hau CM, Sturk A, Nieuwland R. Platelet microparticles contain active caspase 3. Platelets 2008; 19: 96-103. (Pubitemid 351302378)
99. Jy W, Mao WW, Horstman L, et al. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995; 21: 217-31; discussion 231a.
100. Devine DV, Bradley AJ, Maurer E, et al. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999; 39: 724-34. (Pubitemid 29328485)
101. Rank A, Nieuwland R, Crispin A, et al. Clearance of platelet microparticles in vivo. Platelets 2011; 22: 111-6.
102. Schubert P, Devine DV. Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality. J Proteomics 2010; 73: 436-44.
103. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-71. (Pubitemid 46529055)
104. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004; 1636: 119-28. (Pubitemid 38780788)
105. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28. (Pubitemid 38859478)
106. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 2004; 126: 139-52. (Pubitemid 38859495)
107. Morel O, Morel N, Freyssinet JM, Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008; 19: 9-23. (Pubitemid 351171554)
108. Lawrie AS, Harrison P, Cardigan RA, Mackie IJ. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008; 95: 197-204.
109. Matijevic N, Kostousov V, Wang YW, et al. Multiple levels of degradation diminish hemostatic potential of thawed plasma. J Trauma 2011; 70: 71-9; discussion 79-80.
110. Krailadsiri P, Seghatchian J, Macgregor I, et al. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 2006; 46: 407-17. (Pubitemid 43334095)
111. Lawrie AS, Cardigan RA, Williamson LM, et al. The dynamics of clot formation in fresh-frozen plasma. Vox Sang 2008; 94: 306-14. (Pubitemid 351535735)
112. George JN, Pickett EB, Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986; 68: 307-9. (Pubitemid 16033649)
113. Akram A, Teitel JM, Freedman JJ, Gross PL. Hemosta sis in factor VIII deficient mice is improved after the infusion of monocyte-derived microparticles [abstract]. J Thromb Haemost 2007; 5 (Suppl 2): P-M-118.